Atypical Orofacial Pain Diagnostics and Differentiation.
- Conditions
- Persistent Idiopathic Facial Pain
- Interventions
- Behavioral: Self-evaluating questionnairesBehavioral: iMotions analysis platform
- Registration Number
- NCT04775758
- Lead Sponsor
- Lithuanian University of Health Sciences
- Brief Summary
Orofacial pain is diagnosed for more than 1.9 percent of general population and for 0.3 percent origin of the facial pain is unknown. Commonly atypical facial pain is treated as a neurological condition without an emotional or psychiatric evaluation. Since atypical pain and mood affective disorders can be related, patients do not receive proper care for this condition.
The aim of this study is to evaluate the relationship between atypical facial pain syndrome and affective mood disorders. We aim to assess patients' with no diagnosed organic pathology tendency towards anxiety, depression, sleep disorders and one of big five personality traits through self-rating questionnaires. We will compare the gathered data with biosensors from iMotions software.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 150
Not provided
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- FACTORIAL
- Arm && Interventions
Group Intervention Description Maxillofacial fracture pain group iMotions analysis platform Patients with maxillofacial fracture (S02.3, S02.4, S02.6.) will be subjected into control group. Patients included in this study will undergo self-evaluating questionnaires and objective data analysis with facial expression analysis, galvanic skin response and heart rate. All tests are performed in one visit which will last up to an hour. Atypical facial pain group Self-evaluating questionnaires Patients with clinally diagnosed G50.1 - atypical pain condition after all necessary diagnostic measures are taken to exclude a clear organic pathology (multiple diagnostic tests including MRI, CT and consultations from other specialists). Patients included in this study will undergo self-evaluating questionnaires and objective data analysis with facial expression analysis, galvanic skin response and heart rate. All tests are performed in one visit which will last up to an hour. Maxillofacial fracture pain group Self-evaluating questionnaires Patients with maxillofacial fracture (S02.3, S02.4, S02.6.) will be subjected into control group. Patients included in this study will undergo self-evaluating questionnaires and objective data analysis with facial expression analysis, galvanic skin response and heart rate. All tests are performed in one visit which will last up to an hour. Atypical facial pain group iMotions analysis platform Patients with clinally diagnosed G50.1 - atypical pain condition after all necessary diagnostic measures are taken to exclude a clear organic pathology (multiple diagnostic tests including MRI, CT and consultations from other specialists). Patients included in this study will undergo self-evaluating questionnaires and objective data analysis with facial expression analysis, galvanic skin response and heart rate. All tests are performed in one visit which will last up to an hour.
- Primary Outcome Measures
Name Time Method Visual analog scale Assessment score gathered once (Day 1) Patients evaluate their spontaneous episodic pain before assessing self-evaluating questionnaires. Patient pain will be assessed using a visual analogue scale of 0-10, zero being no pain, ten being an unbearable/unimaginable pain. The higher score may lead to a possibilty of developing mood disorders.
Hospital anxiety and depression scale Assessment score gathered once (Day 1) The Hospital anxiety and depression scale is a fourteen-item scale. Seven of the items relate to anxiety and seven relate to depression. The anxiety and depression subscales each range from 0 to 21, with higher scores indicating higher anxiety/depression complains. Patients were defined as having anxiety or depression or both if the score was 8 or more in the corresponding subscale.
Pittsburgh sleep quality index Assessment score gathered once (Day 1) The Pittsburgh Sleep Quality Index contains 19 self-rated questions which measures seven aspects of sleep: (1) subjective sleep quality, (2) sleep latency, (3) sleep duration, (4) habitual sleep efficiency, (5) sleep disturbances, (6) use of sleeping medication, and (7) daytime dysfunction. The 19 self-rated items are combined to form seven component scores, each of which has a range of 0-3 points (0 indicates no difficulty, while 3 indicates severe difficulty). The seven component scores are then summed to yield one global score, with a range of 0-21 points (0 indicating no difficulty, and 21 indicating severe difficulties in all the seven areas of sleep quality).
Big Five personality traits Assessment score gathered once (Day 1) Big five personality traits questionnaire is a 25-item questionnaire compiled from Goldberg et al. 1999. Respondent chooses between a pair of adjectives and chooses an according score from one to seven. All personality dimensions are evaluated separately from specific pairs of adjectives and sum of these pairs scores. Lithuanian version is adapted from A.Bunevičius (2006).
Galvanic skin response. Valence Assessment score gathered once (Day 1) Galvanic skin response peaks (countable) either total or within positive, negative and neutral condition valence.
Galvanic skin response. Amplitude Assessment score gathered once (Day 1) Galvanic skin response is measured in microsiemens. Sudden rise in skin conductivity is called a peak. Peak amplitudes (in microsiemens) will be recorded and analysed. Average amplitude of peaks, either total or within positive, negative and neutral valence.
Galvanic skin response. Peaks/minute Assessment score gathered once (Day 1) Peaks/minute (normalized measure) either total or within positive, negative and neutral valence.
Facial expression analysis. Duration of positive valence. Assessment score gathered once (Day 1) Facial expression analysis determines the respondents' valence (negative, positive or neutral). The duration of positive valence (more than 30 percent threshold) will be assessed seconds.
Facial expression analysis. Duration of negative valence. Assessment score gathered once (Day 1) Facial expression analysis determines the respondents' valence (negative, positive or neutral), the duration of negative valence (less than 30 percent threshold) will be assessed in seconds.
Facial expression analysis. Duration of neutral valence. Assessment score gathered once (Day 1) Facial expression analysis determines the respondents' valence (negative, positive or neutral). The duration of neutral valence (from -30 percent to 30 percent threshold) will be assessed in seconds.
Facial expression analysis. Total duration. Assessment score gathered once (Day 1) Facial expression analysis determines the respondents' valence (negative, positive or neutral). A total duration of the record (measuring time in seconds) will be used.
- Secondary Outcome Measures
Name Time Method Facial expression analysis (raw data) Assessment score gathered once (Day 1) Average of probability scores for each emotion and facial expression.
Heart rate Assessment score gathered once (Day 1) Using optical pulse sensors we aim to register beats per minute throughout the whole participation of the respondents.
Facial expression analysis threshold Assessment score gathered once (Day 1) Fraction of time that an emotion or facial expression crosses the threshold of 30 percent.
Trial Locations
- Locations (1)
Lithuanian University of Health Sciences Kaunas Clinics
🇱🇹Kaunas, Lithuania